Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0021051 (
immunodeficiency
)
71,517
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The CC chemokine receptor 5 (CCR5) is a major co-receptor for human
immunodeficiency
virus (HIV) and CCR5 mutants lacking the carboxy (C)-terminus interfere with HIV infection. Therefore, we analysed the C-terminus of CCR5 and here describe
Jena-Muenchen 4
(
JM4
), a novel CCR5-interacting protein.
JM4
is membrane-associated, co-precipitates with CCR5, and is ubiquitously expressed. It shares about 62% sequence similarity with JWA and glutamate transporter-associated protein 3-18 (GTRAP3-18), a regulator of an amino acid transporter. JWA, like
JM4
, is a four-transmembrane protein, which binds to the CCR5 receptor. Furthermore,
JM4
, JWA, and GTRAP3-18 co-localise and heterodimerise indicating a functional relationship.
JM4
co-localises with calnexin in the endoplasmic reticulum and with the mannose 6-phosphate receptor in the Golgi.
JM4
and GTRAP3-18 harbor a Rab-acceptor motif, indicating a function in vesicle formation at the Golgi complex. In conclusion, we describe a CCR5-interacting protein, which is suggested to function in trafficking and membrane localisation of the receptor, possibly also other receptors or amino acid transporters.
...
PMID:JM4 is a four-transmembrane protein binding to the CCR5 receptor. 1575 71